KL
Kaleido Biosciences, Inc.
KLDO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $12.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
36 /100
Moderate EPS volatility 47.42%
Profitable years 0
Beta -1.17x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KLDO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Wingertzahn
Employees
76
Headquarters
Lexington
Upcoming events
02 NOV
Earnings
Upcoming earnings report